Free. Unsubscribe any time.
Artiva Biotherapeutics, Inc. (ARTV)
Artiva Biotherapeutics, Inc. filed 7 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 2 reporting owners, covering 7 transactions and 92,642 shares. 5 carry the SEC's AFF10B5ONE flag; 2 name a plan only in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-09, came 9 days after the one before it (2026-08-31) and reports 1 transaction against 3 in the filing before it.
- The sales it reports total 23,429 shares, 15,207 more than the 8,222 in the filing before it.
- Its 7 plan statements rank 417th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 5 have more plan statements on file than it, 4 have fewer and 1 has the same number.
- Its 7 filings on file run from 2025-08-18 to 2026-09-09, and state 3 plan adoption dates, from 2024-07-23 to 2026-05-14.
Trades in Artiva Biotherapeutics, Inc. 7
- Aslan Fred — 2025-08-15 · S · 25,500 shares
- Aslan Fred — 2025-10-17 · S · 25,500 shares
- Aslan Fred — 2025-11-17 · S · 6,375 shares
- Aslan Fred — 2025-12-15 · S · 3,187 shares
- Banerjee Subhashis — 2026-08-18 · S · 429 shares
- Banerjee Subhashis — 2026-08-27 · S · 8,222 shares
- Aslan Fred — 2026-09-08 · S · 23,429 shares
Adoption dates in Artiva Biotherapeutics, Inc. 3
- 2024-07-23 — stated in 4 filings
- 2026-05-13 — stated in 1 filing
- 2026-05-14 — stated in 2 filings
Results prints in Artiva Biotherapeutics, Inc. 7
- 2025-03-24
- 2025-05-08
- 2025-08-06
- 2025-11-12
- 2026-03-10
- 2026-05-08
- 2026-08-06
Trades before a print in Artiva Biotherapeutics, Inc. 0
- 26 days before the 2025-11-12 print — 2025-10-17 · S · Aslan Fred · 25,500 shares
- 85 days before the 2026-03-10 print — 2025-12-15 · S · Aslan Fred · 3,187 shares
- 89 days before the 2025-11-12 print — 2025-08-15 · S · Aslan Fred · 25,500 shares
- 113 days before the 2026-03-10 print — 2025-11-17 · S · Aslan Fred · 6,375 shares
Interval to Artiva Biotherapeutics, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- 26shortest, days
- 3no later print
Adoption dates Artiva Biotherapeutics, Inc. states
- 2024-07-23 in 4 filings
- 2026-05-13 in 1 filing
- 2026-05-14 in 2 filings
Filing text: “10b5-1 Plan adopted by the reporting person on July 23, 2024”
Reported results dates on file
- 2025-03-24
- 2025-05-08
- 2025-08-06
- 2025-11-12
- 2026-03-10
- 2026-05-08
- 2026-08-06
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.